Skip to main content
. Author manuscript; available in PMC: 2016 Sep 27.
Published in final edited form as: Am J Biochem Biotechnol. 2008;4(2):114–120. doi: 10.3844/ajbbsp.2008.114.120

Table 1.

Plasma IL-23 and IL-17 levels from subjects with autism and typically developing subjects. Median values plus inter quartile ranges of IL-23 and IL-17 plasma levels are shown from children diagnosed with Early onset autism (AU), Regressive AU, combined AU subjects, and typically developing (TD) subjects. IL-23 levels were significantly different between Early onset AU and typically developing subjects using Student's t-test

Early onset AU (n=20) Regressive AU (n=20) Combined AU subjects (n=40) Typically Developing (n=20)
Median IL-23 (pg mL−1) 4.25** 5.78 5.05* 12.48
(Q1-Q3) (2.82-10.33) (4.01-14.81) (3.51-11.16) (3.79-17.15)
Median IL-17 pg mL−1 1.32 1.78 1.37 1.81
(Q1-Q3) (1.01- 1.74) (1.10- 2.56) (1.06- 2.36) (1.27- ,2.18)
*

p<0.05,

**

p<0.005